Expert Perspectives on a 76-Year-Old Man with Relapsed DLBCL

home / case-based-peer-perspectives / expert-perspectives-on-a-76-year-old-man-with-relapsed-dlbcl

John Burke, MD, reviews the case of a 76-year-old man with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) while analyzing current and future treatment options in R/R DLBCL.

John Burke, MD

EP. 1: Case Presentation: Diffuse Large B-cell Lymphoma

John M. Burke, MD
May 3rd 2021

John Burke, MD, presents a case of a 76-year-old man with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).

Watch

John Burke, MD

EP. 2: Frontline Treatment Options for R/R DLBCL

John M. Burke, MD
May 3rd 2021

John Burke, MD, discusses frontline treatment options for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).

Watch

John Burke, MD

EP. 3: Second-line Treatment Recommendations for R/R DLBCL

John M. Burke, MD
May 3rd 2021

John Burke, MD, considers factors for initiating second-line treatment in relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).

Watch

John Burke, MD

EP. 4: L-Mind Trial and Implications for R/R DLBCL

John M. Burke, MD
May 3rd 2021

John Burke, MD, reviews the practical implications and role of tafasitamab and lenalidomide in addition to reviewing significant results from the L-MIND trial.

Watch

John Burke, MD

EP. 5: Novel Therapies for R/R DLBCL

John M. Burke, MD
May 3rd 2021

John Burke, MD, reflects on current novel therapies used in the treatment of relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).

Watch

John Burke, MD

EP. 6: Clinical Pearls for Managing R/R DLBCL

John M. Burke, MD
May 3rd 2021

John Burke, MD, provides clinical pearls in the recognition in treatment of relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).

Watch